EU MDR has significantly increased the demand for post-market clinical evidence. Learn how Teleflex is transforming real-world evidence (RWE) and registry programs to achieve continuous compliance and maximize market access.

Hear Teleflex’s strategies for turning RWE into regulatory-grade clinical evidence. Watch on-demand to learn how to:

  • Embed RWE and registry programs into long-term product lifecycle strategy
  • Align RWE and registry design with notified bodies and regulators for faster MDR approval
  • Set up and implementing programs to drive operational success
  • Use statistical methodology and data governance to achieve scientific integrity

Bio image

John McDonald

Senior Director Clinical Evidence Generation
Teleflex

John is a senior clinical and medical affairs leader with 20 years experience in the medical device industry designing and executing clinical strategy that drive regulatory approval and market adoption. He has led global clinical programs supporting FDA, MDR, and international registrations, ensuring compliance with evolving regulatory landscapes. John is passionate about translating robust clinical evidence into actionable insights that improve patient outcomes and business success.

Bio image

Stéphanie Flipo

Director, Clinical Strategy
Veeva MedTech

Stéphanie is a clinical expert with 20 years of experience in the medtech industry spanning the end-to-end clinical development process. She drives the European clinical strategy within Veeva MedTech, guiding medtech organization through their clinical transformation journey to accelerate clinical evidence generation using unified technologies and processes.